Torrey Pines Investment, founded in 2002, is a specialty life-science investment company located in San Diego.
Business Model:
Revenue: $18M
Employees: 51-200
Address: 6605 Nancy Ridge Dr
City: San Diego
State: CA
Zip: 92121
Country: US
Torrey Pines Investment, founded in 2002, is a specialty life-science investment company located in San Diego. Torrey Pines has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. Our firm has created biopharma incubators investing in early development stage assets from international pharma and biotech partners in CNS, oncology, and virology areas to bring them to commercial success through pharma partnering and M&a;A. We are committed to capitalizing on the unique opportunities in biotech and pharma, where we can add value in development or regulatory strategy by utilizing resources of our portfolio CRO companies. We seek to leverage our industry knowledge, network of industry and financial contacts, and internal resources to assist our portfolio management in developing and executing their business strategy. Our bottom line is to help our companies achieve growth, build value and realize wealth.
Contact Phone:
+18587240581
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2014 | Precision Repair Network | Venture Round | - |
5/2012 | Biointegrator | Seed Round | - |
5/2017 | TealTech MMO | Venture Round | 400k |
2/2015 | Leap Therapeutics | Seed Round | - |
1/2012 | Aviron | Seed Round | - |
5/2011 | Avineuro | Seed Round | - |
7/2012 | SatRx | Seed Round | - |
5/2010 | Afraxis | Venture Round | 1.2M |
6/2017 | Viriom | Convertible Note | 2.6M |
6/2016 | Chromis Therapeutics | Seed Round | - |
6/2008 | AllaChem | Seed Round | - |
6/2014 | T23 Biopharmaceutical | Venture Round | - |
9/2015 | Viriom | Convertible Note | 3M |
7/2009 | Viriom | Seed Round | - |
4/2012 | Tensha Therapeutics | Funding Round | - |
2/2016 | Chromis Therapeutics | Seed Round | 3M |
9/2014 | Avelas Biosciences | Series B | 7.4M |
1/2014 | Avelas Biosciences | Series B | 6.8M |
4/2012 | Avionco | Seed Round | - |
8/2012 | TeaRx | Seed Round | - |
5/2016 | Viriom | Convertible Note | 0 |
3/2012 | NewVac | Seed Round | - |
6/2017 | Viriom | Convertible Note | 0 |
5/2017 | TealTech MMO | Venture Round | 0 |
6/2016 | Chromis Therapeutics | Seed Round | - |
5/2016 | Viriom | Convertible Note | 0 |
2/2016 | Chromis Therapeutics | Seed Round | 0 |
9/2015 | Viriom | Convertible Note | 0 |
2/2015 | Leap Therapeutics | Seed Round | - |
9/2014 | Avelas Biosciences | Series B | 0 |
6/2014 | T23 Biopharmaceutical | Venture Round | - |
1/2014 | Precision Repair Network | Venture Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|